Johnson & Johnson
JNJ · NYSE
12/29/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $88,821,000 | $85,159,000 | $79,990,000 | $78,740,000 |
| % Growth | 4.3% | 6.5% | 1.6% | – |
| Cost of Goods Sold | $27,471,000 | $26,553,000 | $24,596,000 | $23,402,000 |
| Gross Profit | $61,350,000 | $58,606,000 | $55,394,000 | $55,338,000 |
| % Margin | 69.1% | 68.8% | 69.3% | 70.3% |
| R&D Expenses | $17,232,000 | $15,085,000 | $14,135,000 | $14,277,000 |
| G&A Expenses | $21,969,000 | $20,112,000 | $20,246,000 | $20,118,000 |
| SG&A Expenses | $21,969,000 | $20,112,000 | $20,246,000 | $20,118,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $39,201,000 | $35,197,000 | $34,381,000 | $34,395,000 |
| Operating Income | $22,149,000 | $23,409,000 | $21,013,000 | $20,943,000 |
| % Margin | 24.9% | 27.5% | 26.3% | 26.6% |
| Other Income/Exp. Net | -$5,462,000 | -$8,347,000 | -$1,654,000 | -$1,765,000 |
| Pre-Tax Income | $16,687,000 | $15,062,000 | $19,359,000 | $19,178,000 |
| Tax Expense | $2,621,000 | $1,736,000 | $2,989,000 | $1,377,000 |
| Net Income | $14,066,000 | $35,153,000 | $17,941,000 | $20,878,000 |
| % Margin | 15.8% | 41.3% | 22.4% | 26.5% |
| EPS | 5.84 | 13.88 | 6.83 | 7.93 |
| % Growth | -57.9% | 103.2% | -13.9% | – |
| EPS Diluted | 5.79 | 13.72 | 6.73 | 7.81 |
| Weighted Avg Shares Out | 2,407,300 | 2,533,500 | 2,613,597 | 2,628,965 |
| Weighted Avg Shares Out Dil | 2,429,400 | 2,560,400 | 2,663,900 | 2,674,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,332,000 | $1,261,000 | $490,000 | $53,000 |
| Interest Expense | $755,000 | $772,000 | $276,000 | $183,000 |
| Depreciation & Amortization | $7,339,000 | $7,486,000 | $6,970,000 | $7,390,000 |
| EBITDA | $24,781,000 | $23,320,000 | $26,605,000 | $26,751,000 |
| % Margin | 27.9% | 27.4% | 33.3% | 34% |